Portal de Periódicos da CAPES

Adjuvant Chemotherapy for Stage III Colon Cancer

2005; American Medical Association; Volume: 294; Issue: 21 Linguagem: Inglês

10.1001/jama.294.21.2703

1538-3598

J. Milburn Jessup, Andrew K. Stewart, Frederick L. Greene, Bruce D. Minsky,

Genetic factors in colorectal cancer

A 1990 National Institutes of Health Consensus Conference recommended that patients with stage III colon cancer receive adjuvant chemotherapy because survival was improved in clinical trials in patients who received a 5-fluorouracil-based regimen.